Real-world Insights of People With Human Immunodeficiency Virus (HIV) Infection
RISE
RISE: Real World Insights of People Living With HIV Shared Through Electronic Devices
1 other identifier
observational
1,184
1 country
1
Brief Summary
This study is designed to identify the burden associated with HIV and its treatment, and assess their health-related quality of life (HRQoL) by measuring key HRQoL domains, including satisfaction with treatment and care, and internalised stigma (ISAT). The study will also explore data for various important subpopulations such as subjects who are virally suppressed; who we anticipate will be the majority of study subjects. The study design is an observational, cross sectional study employing subjects' own mobile phone devices for data entry.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 10, 2018
CompletedFirst Posted
Study publicly available on registry
January 17, 2018
CompletedStudy Start
First participant enrolled
January 18, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 7, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 7, 2018
CompletedMarch 11, 2019
March 1, 2019
6 months
January 10, 2018
March 8, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of virally suppressed PLHIV reporting different HRQoL scores
Evaluation of HRQoL will be conducted using scores achieved by Functional Assessment of HIV Infection (FAHI). QoL assessment will include physical well-being, social well-being, emotional well-being, functional and global well-being, and cognitive functioning
Up to 1 Week
Secondary Outcomes (4)
Percentage of virally suppressed PLHIV reporting different satisfaction with care scores
Up to 1 Week
Percent difference in HRQoL scores among subject subgroups
Up to 1 Week
Percentage of subjects reporting different HRQoL scores and relationship with satisfaction with care
Up to 1 Week
Percentage of subjects reporting diffferent HRQoL and medication adherence
Up to 1 Week
Study Arms (1)
Subjects living with HIV
Subjects living with HIV will be recruited via digital advertising. These subjects will participate in completing various PRO instruments and targeted questions.
Interventions
Functional Assessment of HIV Infection will be used to assess HRQoL of subjects. This will include 47 items.
Patient Satisfaction Questionnaire will be used to assess burden and HRQoL in subjects. This will include 18 items.
Symptom Distress Module will be used to assess burden and HRQoL in subjects. This will include 20 items.
Patient Health Questionnaire will be used to assess burden and HRQoL in subjects. This will include 2 items.
Internalized Stigma of AIDS Tool will be used to assess burden and HRQoL in subjects. This will include 10 items.
Medication adherence visual analogue scale will be used to assess burden and HRQoL in subjects. This will include 1 item.
Eligibility Criteria
PLHIV will be recruited advertising in digital media. The study plan is to collect a complete set of data from 3000 PLHIV during a 90-180 day period in the US.
You may qualify if:
- \>= 21 years old
- Language:Read and Understand English / Spanish
- Positive diagnosis of HIV infection by a healthcare provider (self-reported)
- Possesses a smartphone that has internet access
You may not qualify if:
- Not Applicable
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ViiV Healthcarelead
- Evideracollaborator
- mProvecollaborator
Study Sites (1)
GSK Investigational Site
Arlington, Virginia, 22209, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
GSK Clinical Trials
ViiV Healthcare
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 10, 2018
First Posted
January 17, 2018
Study Start
January 18, 2018
Primary Completion
July 7, 2018
Study Completion
July 7, 2018
Last Updated
March 11, 2019
Record last verified: 2019-03